Literature DB >> 3979751

Diltiazem and granulomatous hepatitis.

N S Sarachek, R L London, T J Matulewicz.   

Abstract

A case of granulomatous hepatitis proven by biopsy and related to diltiazem use is described. Clinicians should be alert to the possible presence of this complication in patients who develop fever, laboratory abnormalities, or clinical evidence of hepatic injury while taking diltiazem.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3979751     DOI: 10.1016/s0016-5085(85)80089-5

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  5 in total

Review 1.  A comparative review of the adverse effects of calcium antagonists.

Authors:  H T Dougall; J McLay
Journal:  Drug Saf       Date:  1996-08       Impact factor: 5.606

2.  Acute hepatitis induced by HMG-CoA reductase inhibitor, lovastatin.

Authors:  S Grimbert; D Pessayre; C Degott; J P Benhamou
Journal:  Dig Dis Sci       Date:  1994-09       Impact factor: 3.199

3.  Antianginal effect of conventional and controlled release diltiazem in stable angina pectoris.

Authors:  K Boman; H Saetre; L G Karlsson; B Ritter; R Marsell; H Wingman; O Lövheim; E W Michaeli; P Löfdahl; S O Olsson
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

4.  Verapamil versus hydrochlorothiazide in the treatment of hypertension: results of long term double blind comparative trial. Verapamil versus Diuretic (VERDI) Trial Research Group.

Authors:  H Holzgreve; A Distler; J Michaelis; T Philipp; S Wellek
Journal:  BMJ       Date:  1989-10-07

Review 5.  Drug-induced liver injury: is it somehow foreseeable?

Authors:  Giovanni Tarantino; Matteo Nicola Dario Di Minno; Domenico Capone
Journal:  World J Gastroenterol       Date:  2009-06-21       Impact factor: 5.742

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.